Comprehensive clinical trial delivery across Phase I–III with a focus on quality and efficiency.
With a PhD in Molecular Microbiology from VU Amsterdam, Ronald joined hVIVO consulting in 2015 as an RA-CMC consultant before becoming a senior consultant almost a year later.
Expert in regulatory demands (focus on CMC) for global registrations of biological products, incl. recombinant proteins, vaccines, and ADCs
Skilled in developing RA(-CMC) strategies, regulatory submissions, and liaising with US and EU agencies
Authored scientific advice/Pre-IND briefing packages and served as Sponsor representative during advice procedure
No articles found for this topic.
